Sunshine Biopharma (SBFM) Exchange Rate Effect (2015 - 2026)
Sunshine Biopharma (SBFM) reported Exchange Rate Effect of -$33677.0 for Q1 2026, down 230.26% on a YoY basis from $25852.9 in Q1 2025, and down 104.44% quarter-over-quarter from $758585.0 in Q4 2025.
Sunshine Biopharma (SBFM) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Sunshine Biopharma has reported Exchange Rate Effect for 12 years, with the latest figure at -$33677.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 230.26% year-over-year to -$33677.0; the trailing twelve-month figure through Mar 2026 stood at $832270.0 (up 263.26% YoY), and the FY2025 full-year result was $855750.0, up 182.02% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$33677.0, down from $758585.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $772282.0 in Q3 2024, with the low at -$636577.0 in Q2 2024.
- Historically, Exchange Rate Effect has averaged -$16763.2 across 5 years, with a median of -$11376.0 in 2022.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect surged 3746.35% — and 2024, when it slumped 21944.31%.
- Sunshine Biopharma's Exchange Rate Effect stood at $104542.0 in 2022, then tumbled by 194.34% to -$98626.0 in 2023, then tumbled by 544.15% to -$635298.0 in 2024, then jumped by 219.41% to $758585.0 in 2025, then tumbled by 104.44% to -$33677.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$33677.0 (Q1 2026), $758585.0 (Q4 2025), and -$228322.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2.38 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -22,000.00 |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | -33,677.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,677.00 |
| Mar 31, 2026 | -33,677.00 |
| Dec 31, 2025 | 758,585.00 |
| Dec 31, 2025 | 758,585.00 |
| Sep 30, 2025 | -228,322.00 |
| Sep 30, 2025 | -228,322.00 |
| Jun 30, 2025 | 335,684.00 |
| Jun 30, 2025 | 335,684.00 |
| Mar 31, 2025 | -10,197.00 |
| Mar 31, 2025 | -10,197.00 |
| Dec 31, 2024 | -635,298.00 |
| Dec 31, 2024 | -635,298.00 |
| Sep 30, 2024 | 772,282.00 |
| Sep 30, 2024 | 772,282.00 |
| Jun 30, 2024 | -636,577.00 |
| Jun 30, 2024 | -636,577.00 |
| Mar 31, 2024 | -543,705.00 |
| Mar 31, 2024 | -543,705.00 |
| Dec 31, 2023 | -98,626.00 |
| Dec 31, 2023 | -98,626.00 |